Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial

BACKGROUND: Given the potential role of the 5-hydroxytryptamine-3 receptor in the pathogenesis of schizophrenia, this study was performed to determine whether ondansetron plus risperidone could reduce the negative and depressive symptoms in patients with treatment-resistant schizophrenia. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Samadi, Roya, Soluti, Susan, Daneshmand, Reza, Assari, Shervin, Manteghi, Ali Akhoundpour
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Journal of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337760/
https://www.ncbi.nlm.nih.gov/pubmed/28293046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337760/
https://www.ncbi.nlm.nih.gov/pubmed/28293046

Ejemplares similares